4 unknown. 4 Phase 3, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 4 | Unknown 4 |
| Phase 2 | 1 | Unknown 1 |
Follow Hypertriglyceridemia: new trials by email Literature Review of Hypertriglyceridemia trials Research Report on Hypertriglyceridemia
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Effects of Phytoestrogen From Pueraria Mirifica in Improvement of Serum Lipid Parameters in Postmenopausal Women Phytoestrogen, Diet control & life style modification - Dyslipidemias, Hypertriglyceridemia | Phase 2 / Phase 3 | Unknown | Dhurakij Pundit University | 10 | 2024-03-02 | 2024-05-24 |
| Efficacy and Safety of the Fixed-dose Combination Atorvastatin/Fenofibrate vs Atorvastatin in Patients With T2D and DLP. Atorvastatin 20 mg / Fenofibrate 160 mg in fixed dose, Atorvastatin (Lipitor ®) - Dyslipidemia Associated With Type II Diabetes Mellitus | Phase 3 | Unknown | Laboratorios Silanes S.A. de C.V. | 78 | 2022-02-15 | 2022-03-02 |
| Omega-3-Acid Ethyl Esters 90 Soft Capsules for Lowering Very High Triglycerides Omega-3-Acid Ethyl Esters 90 Soft Capsules, Corn Oil - Hypertriglyceridemia | Phase 3 | Unknown | Jiangsu HengRui Medicine Co., Ltd. | 240 | 2015-12-01 | 2015-12-09 |
| Efficacy Study to Treat Subjects With Severe Hypertriglyceridemia AKR-963 - Severe Hypertriglyceridemia | Phase 3 | Unknown | Trygg Pharma, Inc. | 240 | 2010-10-01 | 2011-11-24 |
Dyslipidemias (2) · Diabetes Mellitus, Type 2 (1) · Hypercholesterolemia (1)
Hyperlipidemias (4) · Lipid Metabolism Disorders (4) · Metabolic Diseases (4) · Nutritional and Metabolic Diseases (4) · Dyslipidemias (2) · Diabetes Mellitus (1) · Endocrine System Diseases (1) · Glucose Metabolism Disorders (1)
Atorvastatin (1) · Corn Oil (1) · Fenofibrate (1) · Phytoestrogens (1)
Dhurakij Pundit University (1) · Jiangsu HengRui Medicine Co., Ltd. (1) · Laboratorios Silanes S.A. de C.V. (1) · Trygg Pharma, Inc. (1)
Mexico (1) · Thailand (1) · United States (1)
Francisco G Padilla Padilla, M.D (1) · Juan A Peraza Zaldivar, M.D (1) · Kevin C Maki, PhD (1) · Prischa Saengow, MD. (1)